Nazmy et al. have found that the tumor suppressor activity of AdipoQ can provide the body with more anti-HCC effects by preventing the decrease of p53 expression, the reactivation of TNF-related apoptosis-inducing ligand signals, and the induction of apoptosis pathways [68]. The gene discussed is TP53; the disease is hepatocellular carcinoma.